DENCODA

1 known investors

DENCODA develops proprietary DNA-sensing probe technology that detects biomarkers for numerous diseases, from osteoarthritis to cancer, from a blood sample. The diagnostics tools are aimed at researchers, research institutions, and healthcare professionals seeking earlier disease insights.

BiotechHealthtechMedical Devices